About
HAS, Growth Factors
Areas of Focus
Categories
Non-PharmaceuticalChina
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
1,045
By Phase
PHASE2: 2PHASE1: 3PHASE3: 1
By Status
COMPLETED: 2ACTIVE_NOT_RECRUITING: 1NOT_YET_RECRUITING: 1UNKNOWN: 1RECRUITING: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06722664Lead Sponsor
Efficacy and Safety of OsrhCT and Dimethicone Emulsion Before Upper Endoscopy on Visualization of the Gastric Mucosa.
PHASE2Active, not recruiting
336 participants
Started: Dec 19, 2024 · Completed: May 15, 2025
NCT06525272Lead Sponsor
A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of OsrhCT in Patients With Pleurisy
PHASE1Not yet recruiting
72 participants
Started: Jul 31, 2024 · Completed: Dec 31, 2025
NCT06355479Lead Sponsor
A Study to Evaluate the Efficacy and Safety of OsrHSA in Patients of Hepatic Cirrhosis With Hypoalbuminemia
PHASE3Completed
328 participants
Started: Apr 10, 2023 · Completed: Dec 12, 2023
NCT05315921Lead Sponsor
Study of OsrhAAT or Placebo in Healthy Volunteers
PHASE1Unknown
48 participants
Started: Mar 22, 2022 · Completed: Jun 30, 2023
NCT04835480Lead Sponsor
A Phase II Study of OsrHSA in Patients With Decompensated Cirrhotic Ascites
PHASE2Recruiting
220 participants
Started: Mar 22, 2021 · Completed: Jun 30, 2022
Locations (1)
Headquarters
Wuhan, China
Map
Loading map...